TY - JOUR
T1 - Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes
AU - Sasaki, Rumi
AU - Narisawa-Saito, Mako
AU - Yugawa, Takashi
AU - Fujita, Masatoshi
AU - Tashiro, Hironori
AU - Katabuchi, Hidetaka
AU - Kiyono, Tohru
PY - 2009
Y1 - 2009
N2 - Ovarian surface epithelium (OSE) is considered to give rise to epithelial ovarian carcinomas (EOCs). To elucidate early processes contributing to the development of EOCs from the OSE, two batches of primary human OSE cells were transduced with non-viral human genes (mutant Cdk4, cyclin D1 and hTERT) so as to efficiently establish normal diploid OSE cells without chromosomal instability. Then defined genetic alterations frequently observed in EOCs were transduced into the OSE cells. A combination of p53 inactivation and oncogenic K ras transduction did not confer tumor-forming ability in immunodeficient mice, though additional transduction of Akt or combined transduction of c-myc with bcl-2 did result in tumor formation. In the latter case, tumors demonstrated phenotypes reminiscent of human EOCs, including cytokeratin expression, a highly aggressive phenotype, metastatic behavior and formation of ascites. These results indicate that inactivation of p53 and activation of the Ras pathway play critical roles in ovarian carcinogenesis in co-operation with the Akt or c-myc pathways. This first in vitro model system faithfully recapitulating the development of EOCs using normal human OSE cells should greatly facilitate further studies of EOCs.
AB - Ovarian surface epithelium (OSE) is considered to give rise to epithelial ovarian carcinomas (EOCs). To elucidate early processes contributing to the development of EOCs from the OSE, two batches of primary human OSE cells were transduced with non-viral human genes (mutant Cdk4, cyclin D1 and hTERT) so as to efficiently establish normal diploid OSE cells without chromosomal instability. Then defined genetic alterations frequently observed in EOCs were transduced into the OSE cells. A combination of p53 inactivation and oncogenic K ras transduction did not confer tumor-forming ability in immunodeficient mice, though additional transduction of Akt or combined transduction of c-myc with bcl-2 did result in tumor formation. In the latter case, tumors demonstrated phenotypes reminiscent of human EOCs, including cytokeratin expression, a highly aggressive phenotype, metastatic behavior and formation of ascites. These results indicate that inactivation of p53 and activation of the Ras pathway play critical roles in ovarian carcinogenesis in co-operation with the Akt or c-myc pathways. This first in vitro model system faithfully recapitulating the development of EOCs using normal human OSE cells should greatly facilitate further studies of EOCs.
UR - http://www.scopus.com/inward/record.url?scp=62349118021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=62349118021&partnerID=8YFLogxK
U2 - 10.1093/carcin/bgp007
DO - 10.1093/carcin/bgp007
M3 - Article
C2 - 19126650
AN - SCOPUS:62349118021
SN - 0143-3334
VL - 30
SP - 423
EP - 431
JO - Carcinogenesis
JF - Carcinogenesis
IS - 3
ER -